Acorah Software Products - Accounts Production 14.5.601 false true false true No description of principal activity 8 July 2022 31 December 2023 31 December 2023 14222815 Dr Nazrul Sirkar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14222815 2022-07-07 14222815 2023-12-31 14222815 2022-07-08 2023-12-31 14222815 frs-bus:CompanyLimitedByGuarantee 2022-07-08 2023-12-31 14222815 frs-bus:FilletedAccounts 2022-07-08 2023-12-31 14222815 frs-bus:Micro-entities 2022-07-08 2023-12-31 14222815 frs-bus:AuditExempt-NoAccountantsReport 2022-07-08 2023-12-31 14222815 frs-bus:Director1 2022-07-08 2023-12-31
Registered number: 14222815
Kidney Foundation
Financial Statements
For the Period 8 July 2022 to 31 December 2023
Shabbir & Co
Chartered Certified Accountants
248 Brockley Road
London
SE4 2SF
Balance Sheet
Registered number: 14222815
31 December 2023
£
Current assets 1,148
NET CURRENT ASSETS 1,148
TOTAL ASSETS LESS CURRENT LIABILITIES 1,148
NET ASSETS 1,148
RESERVES 1,148

Notes

1. General Information
Kidney Foundation is a private company, limited by guarantee, incorporated in England & Wales, registered number 14222815 . The registered office is 33 Newstead Road, London, SE12 0SY.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
3. Company limited by guarantee
The company is limited by guarantee and has no share capital.
Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £10.
Page 0
Page 1
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Nazrul Sirkar
Director
5th April 2024